BCL2 and breast carcinoma: Treatment with the ROS-inducing agent paraquat causes an increase in the Bax/Bcl-2 ratio and subsequent apoptosis in breast cancer cells, which has been found to be mediated by the disruption of the Bcl-2/Bax interaction [47].